{ "labelLang" : "hun", "responseDate" : "2024-03-29 13:29", "content" : { "otype" : "JournalArticle", "mtid" : 26558214, "status" : "APPROVED", "published" : true, "comment" : "N1 Funding details: R01 GM54414, NIH, National Institutes of Health\nN1 Funding text: Thiswork was supported by the National Institutes ofHealth [grant numbers R01 GM54414, R01 HL79430 and R37 HL49234 (to P.G.W.G.), and R01 HL78827 and R37 HL39888 (to S.T.O.)].\nMegjegyzés-26558209\nN1 Funding details: R01 GM54414, NIH, National Institutes of Health\nN1 Funding text: Thiswork was supported by the National Institutes ofHealth [grant numbers R01 GM54414, R01 HL79430 and R37 HL49234 (to P.G.W.G.), and R01 HL78827 and R37 HL39888 (to S.T.O.)].\nPart number: 15", "unhandledTickets" : 0, "oldTimestamp" : "2017-05-05T11:15:55.000+0000", "deleted" : false, "oldId" : 16558214, "lastRefresh" : "2023-01-25T13:58:28.441+0000", "lastModified" : "2019-01-28T15:11:11.510+0000", "created" : "2017-05-05T11:14:54.000+0000", "creator" : { "otype" : "Author", "mtid" : 10015069, "link" : "/api/author/10015069", "label" : "Dobó József (biokémia és immunológia)", "familyName" : "Dobó", "givenName" : "József", "published" : true, "oldId" : 10015069, "snippet" : true }, "lastDuplumSearch" : "2023-01-25T13:55:46.630+0000", "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Gettins, PGW", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 65958116, "link" : "/api/authorship/65958116", "label" : "Gettins, PGW", "listPosition" : 1, "share" : 0.0, "first" : true, "last" : false, "familyName" : "Gettins", "givenName" : "PGW", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 134607642, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 65958117, "link" : "/api/authorship/65958117", "label" : "Olson, ST", "listPosition" : 2, "share" : 0.0, "first" : false, "last" : true, "familyName" : "Olson", "givenName" : "ST", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 134607641, "snippet" : true } ], "title" : "Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 12425945, "link" : "/api/publicationidentifier/12425945", "label" : "DOI: 10.1042/BCJ20160014", "source" : { "otype" : "PlainSource", "mtid" : 6, "link" : "/api/publicationsource/6", "label" : "DOI", "type" : { "otype" : "PublicationSourceType", "mtid" : 10001, "link" : "/api/publicationsourcetype/10001", "label" : "DOI", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "DOI", "nameEng" : "DOI", "linkPattern" : "https://doi.org/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 6, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "10.1042/BCJ20160014", "realUrl" : "https://doi.org/10.1042/BCJ20160014", "published" : false, "oldId" : 14747969, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 15158473, "link" : "/api/publicationidentifier/15158473", "label" : "WoS: 000393713000002", "source" : { "otype" : "PlainSource", "mtid" : 1, "link" : "/api/publicationsource/1", "label" : "WoS", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "WoS", "nameEng" : "WoS", "linkPattern" : "https://www.webofscience.com/wos/woscc/full-record/WOS:@@@", "publiclyVisible" : true, "published" : true, "oldId" : 1, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "000393713000002", "realUrl" : "https://www.webofscience.com/wos/woscc/full-record/WOS:000393713000002", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 12425944, "link" : "/api/publicationidentifier/12425944", "label" : "Scopus: 85009387525", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "85009387525", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85009387525", "published" : false, "oldId" : 14747968, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 15158472, "link" : "/api/publicationidentifier/15158472", "label" : "PubMed: 27470592", "source" : { "otype" : "PlainSource", "mtid" : 17, "link" : "/api/publicationsource/17", "label" : "PubMed", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "PubMed", "nameEng" : "PubMed", "linkPattern" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract", "publiclyVisible" : true, "published" : true, "oldId" : 17, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "27470592", "realUrl" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27470592&dopt=Abstract", "published" : false, "snippet" : true } ], "journal" : { "otype" : "Journal", "mtid" : 683, "link" : "/api/journal/683", "label" : "BIOCHEMICAL JOURNAL 0264-6021 1470-8728", "pIssn" : "0264-6021", "eIssn" : "1470-8728", "reviewType" : "REVIEWED", "noIF" : false, "sciIndexed" : true, "scopusIndexed" : true, "lang" : "FOREIGN", "hungarian" : false, "published" : true, "oldId" : 683, "snippet" : true }, "volume" : "473", "issue" : "15", "firstPage" : "2273", "lastPage" : "2293", "firstPageOrInternalIdForSort" : "2273", "pageLength" : 21, "publishedYear" : 2016, "digital" : null, "printed" : null, "sourceYear" : 2017, "packet" : "504599", "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : false, "conferencePublication" : null, "nationalOrigin" : null, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2023-01-25", "oaFree" : false, "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 3, "citedCount" : 3, "referenceList" : "Hunt, L.T., Dayhoff, M.O., A surprising new protein superfamily containing ovalbumin, antithrombin III and 1-proteinase inhibitor Biochem. Biophys. Res. Commun., 95, pp. 864-871. , CrossRef PubMed; \n\nIrving, J.A., Pike, R.N., Lesk, A.M., Whisstock, J.C., Phylogeny of the serpin superfamily: Implications of patterns of amino acid conservation for structure and function Genome Res, 10, pp. 1845-1864. , CrossRef PubMed; \n\nRoberts, T.H., Hejgaard, J., Serpins in plants and green algae Funct. Integr. Genomics, 8, pp. 1-27. , CrossRef PubMed; \n\nTurner, P.C., Musy, P.Y., Moyer, R.W., Poxvirus Serpins Viroceptors, Virokines and Related Immune Modulators Encoded by DNA Viruses, pp. 67-88. , McFadden, G., ed R. G. Landes Co., Austin; \n\nIrving, J.A., Steenbakkers, P.J.M., Lesk, A.M., Op Den Camp, H.J.M., Pike, R.N., Whisstock, J.C., Serpins in prokaryotes Mol. Biol. Evol., 19, pp. 1881-1890. , CrossRef PubMed; \n\nRoberts, T.H., Hejgaard, J., Saunders, N.F., Cavicchioli, R., Curmi, P.M., Serpins in unicellular Eukarya, Archaea, and Bacteria: Sequence analysis and evolution J. Mol. Evol., 59, pp. 437-447. , CrossRef PubMed; \n\nSchwartz, W.H., Zverlov, V.V., Protease inhibitors in bacteria: An emerging concept for the regulation of bacterial protein complexes Mol. Microbiol., 60, pp. 1323-1326. , CrossRef PubMed; \n\nCarrell, R.W., Travis, J., 1-Antitrypsin and the serpins. Variation and countervariation Trends Biol. Sci., 10, pp. 20-24. , CrossRef; \n\nDunstone, M.A., Whisstock, J.C., Crystallography of serpins and serpin complexes Methods Enzymol, 501, pp. 63-87. , CrossRef PubMed; \n\nHeit, C., Jackson, B.C., McAndrews, M., Wright, M.W., Thompson, D.C., Silverman, G.A., Nebert, D.W., Vasiliou, V., Update of the human and mouse SERPIN gene superfamily Hum. Genomics, 7, p. 22. , CrossRef PubMed; \n\nBock, S.C., Skriver, K., Nielsen, E., Thøgersen, H.C., Wiman, B., Donaldson, V.H., Eddy, R.L., Huber, R., Human C1 inhibitor: Primary structure, cDNA cloning, and chromosomal localization Biochemistry, 25, pp. 4292-4301. , CrossRef PubMed; \n\nPerkins, S.J., Smith, K.F., Amatayakul, S., Ashford, D., Rademacher, T.W., Dwek, R.A., Lachmann, P.J., Harrison, R.A., Two-domain structure of the native and reactive center cleaved forms of C1 inhibitor of human complement by neutron scattering J. Mol. Biol., 214, pp. 751-763. , CrossRef PubMed; \n\nLawrence, D.A., Olson, S.T., Palaniappan, S., Ginsburg, D., Engineering plasminogen activator inhibitor 1 mutants with increased functional stability Biochemistry, 33, pp. 3643-3648. , CrossRef PubMed; \n\nKaslik, G., Kardos, J., Szabó, L., Závodszky, P., Westler, W.M., Markley, J.L., Gráf, L., Effects of serpin binding on the target proteinase: Global stabilization, localized increased structural flexibility, and conserved hydrogen bonding at the active site Biochemistry, 36, pp. 5455-5474. , CrossRef PubMed; \n\nIm, H., Ahn, H.Y., Yu, M.H., Bypassing the kinetic trap of serpin protein folding by loop extension Protein Sci, 9, pp. 1497-1502. , CrossRef PubMed; \n\nYu, M.-H., Lee, K.N., Kim, J., The Z type variation of human 1-antitrypsin causes a protein folding defect Nat. Struct. Biol., 2, pp. 363-367. , CrossRef PubMed; \n\nLomas, D.A., Evans, D.L., Finch, J.T., Carrell, R.W., The mechanism of Z 1-antitrypsin accumulation in the liver Nature, 357, pp. 605-607. , CrossRef PubMed; \n\nElliott, P.R., Bilton, D., Lomas, D.A., Lung polymers in Z 1-antitrypsin deficiency-related emphysema Am. J. Respir. Cell Mol. Biol., 18, pp. 670-674. , CrossRef PubMed; \n\nMahadeva, R., Lomas, D.A., Alpha1-antitrypsin deficiency, cirrhosis and emphysema Thorax, 53, pp. 501-505. , CrossRef PubMed; \n\nMatheson, N.R., Van Halbeek, H., Travis, J., Evidence for a tetrahedral intermediate complex during serpin-proteinase interactions J. Biol. Chem., 266, pp. 13489-13491. , PubMed; \n\nOlson, S.T., Heparin and ionic strength-dependent conversion of antithrombin III from an inhibitor to a substrate of-thrombin J. Biol. Chem., 260, pp. 10153-10160. , PubMed; \n\nPatston, P.A., Gettins, P., Beechem, J., Schapira, M., Mechanism of serpin action: Evidence that C1 inhibitor functions as a suicide substrate Biochemistry, 30, pp. 8876-8882. , CrossRef PubMed; \n\nHood, D.B., Huntington, J.A., Gettins, P.G.W., 1-Proteinase inhibitor variant T345R. Influence of P14 residue on substrate and inhibitory pathways Biochemistry, 33, pp. 8538-8547. , CrossRef PubMed; \n\nWright, H.T., Scarsdale, J.N., Structural basis for serpin inhibitor activity Proteins, 22, pp. 210-225. , CrossRef PubMed; \n\nLawrence, D.A., Ginsburg, D., Day, D.E., Berkenpas, M.B., Verhamme, I.M., Kvassman, J.-O., Shore, J.D., Serpin-protease complexes are trapped as stable acyl-enzyme intermediates J. Biol. Chem., 270, pp. 25309-25312. , CrossRef PubMed; \n\nStratikos, E., Gettins, P.G.W., Major proteinase movement upon covalent serpin-proteinase complex formation Proc. Natl. Acad. Sci. U. S. A., 94, pp. 453-458. , CrossRef PubMed; \n\nStratikos, E., Gettins, P.G.W., Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70Å and full insertion of the reactive center loop into-sheet A Proc. Natl. Acad. Sci. U. S. A., 96, pp. 4808-4813. , CrossRef PubMed; \n\nPeterson, F.C., Gettins, P.G.W., Insight into the mechanism of serpin-proteinase inhibition from 2D [1H-15N] NMR studies of the 69 kDa 1-proteinase inhibitor Pittsburgh-trypsin covalent complex Biochemistry, 40, pp. 6284-6292. , CrossRef PubMed; \n\nHuntington, J.A., Read, R.J., Carrell, R.W., Structure of a serpin-protease complex shows inhibition by deformation Nature, 407, pp. 923-926. , CrossRef PubMed; \n\nBackovic, M., Stratikos, E., Lawrence, D.A., Gettins, P.G.W., Structural similarity of the covalent complexes formed between the serpin plasminogen activator inhibitor-1 and the arginine-specific proteinases trypsin, LMW urokinase, HMW urokinase and tPA: Use of site-specific fluorescent probes of local environment Protein Sci, 11, pp. 1182-1191. , CrossRef PubMed; \n\nDementiev, A., Dobo, J., Gettins, P.G.W., Active site distortion is sufficient for proteinase inhibition by serpins. Structure of the covalent complex of 1-proteinase inhibitor with porcine pancreatic elastase J. Biol. Chem., 281, pp. 3452-3457. , CrossRef PubMed; \n\nSwanson, R., Raghavendra, M.P., Zhang, W., Froelich, C., Gettins, P.G.W., Olson, S.T., Serine and cysteine proteases are translocated to similar extents upon formation of covalent complexes with serpins. Fluorescence perturbation and fluorescence resonance energy transfer mapping of the protease binding site in CrmA complexes with granzyme B and caspase-1 J. Biol. Chem., 282, pp. 2305-2313. , CrossRef PubMed; \n\nDobo, J., Swanson, R., Salvesen, G.S., Olson, S.T., Gettins, P.G.W., Cytokine response modifier A inhibition of initiator caspases results in covalent complex formation and dissociation of the caspase tetramer J. Biol. Chem., 281, pp. 38781-38790. , CrossRef PubMed; \n\nBoatright, K.M., Renatus, M., Scott, F., Sperandio, S., Shin, H., Pedersen, I.M., Ricci, J.E., Salvesen, G.S., A unified model for apical caspase activation Mol. Cell, 11, pp. 529-541. , CrossRef PubMed; \n\nGettins, P.G.W., The F-helix of serpins plays an essential, active role in the proteinase inhibition mechanism FEBS Lett, 523, pp. 2-6. , CrossRef PubMed; \n\nMaddur, A.A., Swanson, R., Izaguirre, G., Gettins, P.G.W., Olson, S.T., Kinetic intermediates en route to the final serpin-protease complex. Studies of complexes of alpha-1-protease inhibitor with trypsin J. Biol. Chem., 288, pp. 32020-32035. , CrossRef PubMed; \n\nZhou, A., Carrell, R.W., Huntington, J.A., The serpin inhibitory mechanism is critically dependent on the length of the reactive center loop J. Biol. Chem., 276, pp. 27541-27547. , CrossRef PubMed; \n\nTesch, L.D., Raghavendra, M.P., Bedsted-Faarvang, T., Gettins, P.G.W., Olson, S.T., Specificity and reactive loop length requirements for CrmA inhibition of serine proteases Protein Sci, 14, pp. 533-542. , CrossRef PubMed; \n\nHuntington, J.A., Fan, B., Karlsson, K.E., Deinum, J., Lawrence, D.A., Gettins, P.G.W., Serpin conformational change in ovalbumin. Enhanced reactive center loop insertion through hinge region mutations Biochemistry, 36, pp. 5432-5440. , CrossRef PubMed; \n\nYamasaki, M., Arii, Y., Mikami, B., Hirose, M., Loop-inserted and thermostabilized structure of P1-P1- cleaved ovalbumin mutant R339T J. Mol. Biol., 315, pp. 113-120. , CrossRef PubMed; \n\nLawrence, D.A., Olson, S.T., Muhammad, S., Day, D.E., Kvassman, J.-O., Ginsburg, D., Shore, J.D., Partitioning of serpin-proteinase reactions between stable inhibition and substrate cleavage is regulated by the rate of serpin reactive center loop insertion into-sheet A J. Biol. Chem., 275, pp. 5839-5844. , CrossRef PubMed; \n\nGettins, P.G.W., Serpin structure, mechanism and function Chem. Rev., 102, pp. 4751-4804. , CrossRef PubMed; \n\nAnfinsen, C.B., Principles that govern the folding of protein chains Science, 181, pp. 223-230. , CrossRef PubMed; \n\nHekman, C.M., Loskutoff, D.J., Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants J. Biol. Chem., 260, pp. 11581-11587. , PubMed; \n\nOnda, M., Nakatani, K., Takahara, S., Nishiyama, M., Takahashi, N., Hirose, M., Cleaved serpin refolds into the relaxed state via a stressed conformer J. Biol. Chem., 283, pp. 17568-17578. , CrossRef PubMed; \n\nStein, P.E., Leslie, A.G.W., Finch, J.T., Carrell, R.W., Crystal structure of uncleaved ovalbumin at 1. 95Å resolution J. Mol. Biol., 221, pp. 941-959. , CrossRef PubMed; \n\nWright, H.T., Qian, H.X., Huber, R., Crystal structure of plakalbumin, a proteolytically nicked form of ovalbumin. Its relationship to the structure of cleaved-1-proteinase inhibitor J. Mol. Biol., 213, pp. 513-528. , CrossRef PubMed; \n\nArii, Y., Hirose, M., Probing the serpin structural-transition mechanism in ovalbumi mutant R339T by proteolytic-cleavage kinetics of the reactive centre loop Biochem. J., 363, pp. 403-409. , CrossRef PubMed; \n\nDolmer, K., Gettins, P.G.W., How the serpin 1 proteinase inhibitor folds J. Biol. Chem., 287, pp. 12425-12432. , CrossRef PubMed; \n\nTsutsui, Y., Dela Cruz, R., Wintrode, P.L., Folding mechanism of the metastable serpin-antitrypsin Proc. Natl. Acad. Sci. U. S. A., 109, pp. 4467-4472. , CrossRef PubMed; \n\nGooptu, B., Chang, W.-S.W., Dafforn, T.R., Carrell, R.W., Read, R.J., Inactive conformation of the serpin 1-antichymotrypsin indicates two-stage insertion of the reactive center loop: Implications for inhibitory function and conformational disease Proc. Natl. Acad. Sci. U. S. A., 97, pp. 67-72. , CrossRef PubMed; \n\nPearce, M.C., Powers, G.A., Feil, S.C., Hansen, G., Parker, M.W., Bottomley, S.P., Identification and characterization of a misfolded serpin formed at physiological temperature J. Mol. Biol., 403, pp. 459-467. , CrossRef PubMed; \n\nLee, C., Seo, E.J., Yu, M.-H., Role of the connectivity of secondary structure segments in the folding of 1-antitrypsin Biochem. Biophys. Res. Commun., 287, pp. 636-641. , CrossRef PubMed; \n\nIm, H., Woo, M.-S., Hwang, K.Y., Yu, M.-H., Interactions causing the kinetic trap in serpin protein folding J. Biol. Chem., 277, pp. 46347-46354. , CrossRef PubMed; \n\nCarrell, R.W., 1-Antitrypsin: Molecular pathology, leukocytes, and tissue damage J. Clin. Invest., 78, pp. 1427-1431. , CrossRef PubMed; \n\nDavis, R.L., Shrimpton, A.E., Holohan, P.D., Bradshaw, C., Feiglin, D., Collins, G.H., Sonderegger, P., Lacbawan, F., Familial dementia caused by polymerization of mutant neuroserpin Nature, 401, pp. 376-379. , PubMed; \n\nMiranda, E., Römisch, K., Lomas, D.A., Mutants of neuroserpin that cause dementia accumulate as polymers within the endoplasmic reticulum J. Biol. Chem., 279, pp. 28283-28291. , CrossRef PubMed; \n\nElliott, P.R., Lomas, D.A., Carrell, R.W., Abrahams, J.P., Inhibitory conformation of the reactive loop of 1-antitrypsin Nat. Struct. Biol., 3, pp. 676-681. , CrossRef PubMed; \n\nBehrens, M.A., Sendall, T.J., Pedersen, J.S., Kjeldgaard, M., Huntington, J.A., Jensen, J.K., The shapes of Z-1-antitrypsin polymers in solution support the C-terminal domain-swap mechanism of polymerization Biophys. J., 107, pp. 1905-1912. , CrossRef PubMed; \n\nRicagno, S., Caccia, S., Sorrentino, G., Antonini, G., Bolognesi, M., Human neuroserpin: Structure and time-dependent inhibition J. Mol. Biol., 388, pp. 109-121. , CrossRef PubMed; \n\nKim, J., Lee, K.N., Yi, G.-S., Yu, M.-H., A thermostable mutation located at the hydrophobic core of 1-antitrypsin suppresses the folding defect of the Z-type variant J. Biol. Chem., 270, pp. 8597-8601. , CrossRef PubMed; \n\nTan, L., Dickens, J.A., Demeo, D.L., Miranda, E., Perez, J., Rashid, S.T., Day, J., Haq, I., Circulating polymers in 1-antitrypsin deficiency Eur. Respir. J., 43, pp. 1501-1504. , CrossRef PubMed; \n\nMahadeva, R., Atkinson, C., Li, Z., Stewart, S., Janciauskiene, S., Kelley, D.G., Parmar, J., Lomas, D.A., Polymers of Z 1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo Am. J. Pathol., 166, pp. 377-386. , CrossRef PubMed; \n\nVan'T Wout, E.F.A., Van Schadewijk, A., Lomas, D.A., Stolk, J., Marciniak, S.J., Hiemstra, P.S., Function of monocytes and monocyte-derived macrophages in 1-antitrypsin deficiency Eur. Respir. J., 45, pp. 365-376. , CrossRef PubMed; \n\nYamasaki, M., Li, W., Johnson, D.J.D., Huntington, J.A., Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization Nature, 455, pp. 1255-1259. , CrossRef PubMed; \n\nKnaupp, A.S., Bottomley, S.P., Structural change in-sheet A of Z 1-antitrypsin is responsible for accelerated polymerization and disease J. Mol. Biol., 413, pp. 888-898. , CrossRef PubMed; \n\nMahadeva, R., Dafforn, T.R., Carrell, R.W., Lomas, D.A., 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z 1-antitrypsin-related cirrhosis J. Biol. Chem., 277, pp. 6771-6774. , CrossRef PubMed; \n\nKrishnan, B., Gierasch, L.M., Dynamic local unfolding in the serpin-1 antitrypsin provides a mechanism for loop insertion and polymerization Nat. Struct. Mol. Biol., 18, pp. 222-226. , CrossRef PubMed; \n\nYamasaki, M., Sendall, T.J., Pearce, M.C., Whisstock, J.C., Huntington, J.A., Molecular basis of 1-antitrypsin deficiency revealed by the structure of a domain-swapped trimer EMBO Rep, 12, pp. 1011-1107. , CrossRef PubMed; \n\nMiranda, E., Perez, J., Ekeowa, U.I., Hadzic, N., Kalsheker, N., Gooptu, B., Portmann, B., Chambers, S., A novel monoclonal antibody to characterize pathogenic polymers in liver disease associated with 1-antitrypsin deficiency Hepatology, 52, pp. 1078-1088. , CrossRef PubMed; \n\nSivasothy, P., Dafforn, T.R., Gettins, P.G.W., Lomas, D.A., Pathogenic 1-antitrypsin polymers are formed by reactive loop-sheet A linkage J. Biol. Chem., 275, pp. 33663-33668. , CrossRef PubMed; \n\nEkeowa, U.I., Freeke, J., Miranda, E., Gooptu, B., Bush, M.F., Perez, J., Teckman, J., Lomas, D.A., Defining the mechanism of polymerization in the serpinopathies Proc. Natl. Acad. Sci. U. S. A., 107, pp. 17146-17151. , CrossRef PubMed; \n\nLomas, D.A., Finch, J.T., Seyama, K., Nukiwa, T., Carrell, R.W., 1-Antitrypsin Siiyama (Ser53æPhe), Further evidence for intracellular loop-sheet polymerization J. Biol. Chem., 268, pp. 15333-15335. , PubMed; \n\nOrdonez, A., Perez, J., Tan, J., Dickens, J.A., Motamedi-Shad, N., Irving, J.A., Haq, I., Lomas, D.A., A single-chain variable fragment intrabody prevents intracellular polymerization of Z 1-antitrypsin while allowing its antiprotease activity FASEB J, 29, pp. 2667-2678. , CrossRef PubMed; \n\nKvassman, J.O., Verhamme, I., Shore, J.D., Inhibitory mechanism of serpins: Loop insertion forces acylation of plasminogen activator by plasminogen activator inhibitor-1 Biochemistry, 37, pp. 15491-15502. , CrossRef PubMed; \n\nOlson, S.T., Swanson, R., Day, D., Verhamme, I., Kvassman, J., Shore, J.D., Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1 with tissue plasminogen activator and trypsin Biochemistry, 40, pp. 11742-11756. , CrossRef PubMed; \n\nIzaguirre, G., Swanson, R., Raja, S.M., Rezaie, A.R., Olson, S.T., Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin J. Biol. Chem., 282, pp. 33609-33622. , CrossRef PubMed; \n\nBlouse, G.E., Perron, M.J., Kvassman, J., Yunus, S., Thompson, J.H., Betts, R.L., Lutter, L.C., Shore, J.D., Mutation of the conserved tryptophan in the serpin breach region alters the inhibitory mechanism of plasminogen activator inhibitor-1 Biochemistry, 42, pp. 12260-12272. , CrossRef PubMed; \n\nTakahashi, N., Terakado, K., Nakamura, G., Soekmadji, C., Masuoka, T., Yamasakio, M., Hirose, M., Dynamic mechanism for the serpin loop insertion as revealed by quantitative kinetics J. Mol. Biol., 348, pp. 409-418. , CrossRef PubMed; \n\nVleugels, N., Gils, A., Bijnens, A.-P., Knockaert, I., Declerck, P., The importance of helix F in plasminogen activator inhibitor-1 Biochim. Biophys. Acta, 1476, pp. 20-26. , CrossRef PubMed; \n\nBijnens, A.-P., Gils, A., Knockaert, I., Stassen, J.M., Declerck, P.J., Importance of the hinge region between-helix F and the main part of serpins, based upon identification of the epitope of plasminogen activator inhibitor type 1 neutralizing antibodies J. Biol. Chem., 275, pp. 6375-6380. , CrossRef PubMed; \n\nKomissarov, A.A., Zhou, A., Declerck, P.J., Modulation of serpin reaction through stabilization of transient intermediate by ligands bound through-helix F J. Biol. Chem., 282, pp. 26306-26315. , CrossRef PubMed; \n\nTsutsui, Y., Liu, L., Gershenson, A., Wintrode, P.L., The conformational dynamics of a metastable serpin studied by hydrogen exchange and mass spectrometry Biochemistry, 45, pp. 6561-6569. , CrossRef PubMed; \n\nCabrita, L.D., Whisstock, J.C., Bottomley, S.P., Probing the role of the F-helix in serpin stability through a single tryptophan substitution Biochemistry, 41, pp. 4575-4581. , CrossRef PubMed; \n\nWind, T., Jensen, J.K., Dupont, D.M., Kulig, P., Andreasen, P.A., Mutational analysis of plasminogen activator inhibitor-1. Interactions of-helix F and its neighbouring structural elements regulates the activity and the rate of latency transition Eur. J. Biochem., 270, pp. 1680-1688. , CrossRef PubMed; \n\nLee, C., Park, S.H., Lee, M.Y., Yu, M.H., Regulation of protein function by native metastability Proc. Natl. Acad. Sci. U. S. A., 97, pp. 7727-7731. , CrossRef PubMed; \n\nSengupta, T., Tsutsui, Y., Wintrode, P.L., Local and global effects of a cavity filling mutation in a metastable serpin Biochemistry, 48, pp. 8233-8240. , CrossRef PubMed; \n\nTew, D.J., Bottomley, S.P., Intrinsic fluorescence changes and rapid kinetics of proteinase deformation during serpin inhibition FEBS Lett, 494, pp. 30-33. , CrossRef PubMed; \n\nPerron, M.J., Blouse, G.E., Shore, J.D., Distortion of the catalytic domain of tissue-type plasminogen activator by plasminogen activator inhibitor-1 coincides with the formation of stable serpin-proteinase complexes J. Biol. Chem., 278, pp. 48197-48203. , CrossRef PubMed; \n\nFutamura, A., Stratikos, E., Olson, S.T., Gettins, P.G.W., Change in environment of the P1 side chain upon progression from the Michaelis complex to the covalent serpin-proteinase complex Biochemistry, 37, pp. 13110-13119. , CrossRef PubMed; \n\nBock, P.E., Olson, S.T., Björk, I., Inactivation of thrombin by antithrombin is accompanied by inactivation of regulatory exosite 1 J. Biol. Chem., 272, pp. 19837-19845. , CrossRef PubMed; \n\nStavridi, E.S., O'Malley, K., Lukacs, C.M., Moore, W.T., Lambris, J.D., Christianson, D.W., Rubin, H., Cooperman, B.S., Structural change in-chymotrypsin induced by complexation with 1-antichymotrypsin as seen by enhanced sensitivity to proteolysis Biochemistry, 35, pp. 10608-10615. , CrossRef PubMed; \n\nCalugaru, S.V., Swanson, R., Olson, S.T., The pH dependence of serpin-proteinase complex dissociation reveals a mechanism of complex stabilization involving inactive and active conformational states of the proteinase which are perturbable by calcium J. Biol. Chem., 276, pp. 32446-32455. , CrossRef PubMed; \n\nVan Boven, H.H., Lane, D.A., Antithrombin and its inherited deficiency states Semin. Hematol., 34, pp. 188-204. , PubMed; \n\nIshiguro, K., Kojima, T., Kadomatsu, K., Nakayama, Y., Takagi, A., Suzuki, M., Takeda, N., Matsushita, T., Complete antithrombin deficiency in mice results in embryonic lethality J. Clin. Invest., 106, pp. 873-878. , CrossRef PubMed; \n\nLiu, Y., Kretz, C.A., Maeder, M.L., Richter, C.E., Tsao, P., Vo, A.H., Huarng, M.C., Mehra, R., Targeted mutagenesis of zebrafish antithrombin III triggers disseminated intravascular coagulation and thrombosis, revealing insight into function Blood, 124, pp. 142-150. , CrossRef PubMed; \n\nDe Agostini, A., Watkins, S.C., Slayter, H.S., Youssoufian, H., Rosenberg, R.D., Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: Antithrombin binding on cultured endothelial cells and perfused rat aorta J. Cell Biol., 111, pp. 1293-1304. , CrossRef PubMed; \n\nOlson, S.T., Swanson, R., Raub-Segall, E., Bedsted, T., Sadri, M., Petitou, M., Hérault, J.-M., Björk, I., Accelerating ability of synthetic oligosacccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems Thromb. Haemost., 92, pp. 929-939. , PubMed; \n\nOlson, S.T., Björk, I., Sheffer, R., Craig, P.A., Shore, J.D., Choay, J., Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement J. Biol. Chem., 267, pp. 12528-12538. , PubMed; \n\nJin, L., Abrahams, J.P., Skinner, R., Petitou, M., Pike, R.N., Carrell, R.W., The anticoagulant activation of antithrombin by heparin Proc. Natl. Acad. Sci. U. S. A., 94, pp. 14683-14688. , CrossRef PubMed; \n\nPetitou, M., Casu, B., Lindahl, U., 1976-1983 a critical period in the history of heparin: The discovery of the antithrombin binding site Biochimie, 85, pp. 83-89. , CrossRef PubMed; \n\nBedsted, T., Swanson, R., Chuang, Y.-J., Bock, P.E., Björk, I., Olson, S.T., Heparin and calcium ions dramatically enhance antithrombin reactivity with factor IXa by generating new interaction exosites Biochemistry, 42, pp. 8143-8152. , CrossRef PubMed; \n\nOlson, S.T., Björk, I., Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects J. Biol. Chem., 266, pp. 6353-6364. , PubMed; \n\nRezaie, A.R., Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. Evidence that calcium alleviates Gla domain antagonism of heparin binding to factor Xa J. Biol. Chem., 273, pp. 16824-16827. , CrossRef PubMed; \n\nDesai, U.R., Petitou, M., Björk, I., Olson, S.T., Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide in the recognition of native and activated states of antithrombin J. Biol. Chem., 273, pp. 7478-7487. , CrossRef PubMed; \n\nDesai, U.R., Petitou, M., Björk, I., Olson, S.T., Mechanism of heparin activation of antithrombin: Evidence for an induced-fit model of allosteric activation involving two interaction subsites Biochemistry, 37, pp. 13033-13041. , CrossRef PubMed; \n\nGettins, P.G.W., Fan, B., Crews, B.C., Turko, I.V., Olson, S.T., Streusand, V.J., Transmission of conformational change from the heparin binding site to the reactive center of antithrombin Biochemistry, 32, pp. 8385-8389. , CrossRef PubMed; \n\nPike, R.N., Potempa, J., Skinner, R., Fitton, H.L., McGraw, W.T., Travis, J., Owen, M., Carrell, R.W., Heparin-dependent modification of the reactive center arginine of antithrombin and consequent increase in heparin binding affinity J. Biol. Chem., 272, pp. 19652-19655. , CrossRef PubMed; \n\nChuang, Y.-J., Swanson, R., Raja, S.M., Olson, S.T., Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin J. Biol. Chem., 276, pp. 14961-14971. , CrossRef PubMed; \n\nManithody, C., Yang, L., Rezaie, A.R., Role of basic residues of the autolysis loop in the catalytic function of factor Xa Biochemistry, 41, pp. 6780-6788. , CrossRef PubMed; \n\nIzaguirre, G., Zhang, W., Swanson, R., Bedsted, T., Olson, S.T., Localization of an antithrombin exosite that promotes rapid inhibition of factors Xa and IXa on heparin activation of the serpin J. Biol. Chem., 279, pp. 51433-51440. , CrossRef; \n\nIzaguirre, G., Olson, S.T., Residues Tyr253 and Glu255 in strand 3 of-sheet C of antithrombin are key determinants of an exosite made accessible by heparin activation to promote rapid inhibition of factors Xa and IXa J. Biol. Chem., 281, pp. 13424-13432. , CrossRef PubMed; \n\nJohnson, D.J.D., Li, W., Adams, T.E., Huntington, J.A., Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation EMBO J, 25, pp. 2029-2037. , CrossRef PubMed; \n\nJohnson, D.J.D., Langdown, J., Huntington, J.A., Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1. 7Å structure of the ternary complex Proc. Natl. Acad. Sci. U. S. A., 107, pp. 645-650. , CrossRef PubMed; \n\nDementiev, A., Petitou, M., Herbert, J.M., Gettins, P.G.W., The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity Nat. Struct. Mol. Biol., 11, pp. 863-867. , CrossRef PubMed; \n\nLi, W., Johnson, D.J., Esmon, C.T., Huntington, J.A., Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin Nat. Struct. Mol. Biol., 11, pp. 857-862. , CrossRef PubMed; \n\nHopkins, P.C.R., Pike, R.N., Stone, S.R., Evolution of serpin specificity: Cooperative interactions in the reactive-site loop sequence of antithrombin specifically restrict the inhibition of activated protein C J. Mol. Evol., 51, pp. 507-515. , PubMed; \n\nGettins, P.G.W., Olson, S.T., Activation of antithrombin as a factor IXa and Xa inhibitor involves mitigation of repression rather than positive enhancement FEBS Lett., 583, pp. 3397-3400. , CrossRef PubMed; \n\nDementiev, A., Swanson, R., Roth, R., Isetti, G., Izahuirre, G., Olson, S.T., Gettins, P.G.W., The allosteric mechanism of activation of antithrombin as an inhibitor of factor IXa and Factor Xa. Heparin-independent full activation through mutations adjacent to helix D J. Biol. Chem., 288, pp. 22611-33619. , CrossRef; \n\nMeagher, J.L., Beechem, J.M., Olson, S.T., Gettins, P.G.W., Deconvolution of the fluorescence emission spectrum of human antithrombin and identification of the tryptophan residues that are responsive to heparin binding J. Biol. Chem., 273, pp. 23283-23289. , CrossRef PubMed; \n\nMeagher, J.L., Olson, S.T., Gettins, P.G.W., Critical role of the linker region between helix D and strand 2A in heparin activation of antithrombin J. Biol. Chem., 275, pp. 2698-2704. , CrossRef PubMed; \n\nBelzar, K.J., Zhou, A., Carrell, R.W., Gettins, P.G.W., Huntington, J.A., Helix D elongation and allosteric activation of antithrombin J. Biol. Chem., 277, pp. 8551-8558. , CrossRef PubMed; \n\nIzaguirre, G., Aguila, S., Qi, L., Swanson, R., Roth, R., Rezaie, A.R., Gettins, P.G.W., Olson, S.T., Conformational activation of antithrombin by heparin involves altered exosite interaction with protease J. Biol. Chem., 289, pp. 34049-34064. , CrossRef PubMed; \n\nRoth, R., Swanson, R., Izaguirre, G., Bock, S.C., Gettins, P.G.W., Olson, S.T., Saturation mutagenesis of the antithrombin reactive center loop P14 residue supports a three-step mechanism of heparin allosteric activation involving intermediate and fully activated states J. Biol. Chem., 290, pp. 28020-28036. , CrossRef PubMed; \n\nHuntington, J.A., Olson, S.T., Fan, B., Gettins, P.G.W., Mechanism of heparin activation of antithrombin. Evidence for reactive center loop pre-insertion with expulsion upon heparin binding Biochemistry, 35, pp. 8495-8503. , CrossRef PubMed; \n\nHuntington, J.A., Gettins, P.G.W., Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin Biochemistry, 37, pp. 3272-3277. , CrossRef PubMed; \n\nFutamura, A., Gettins, P.G.W., Serine 380 (P14) to glutamate mutation activates antithrombin as an inhibitor of factor Xa J. Biol. Chem., 275, pp. 4092-4098. , CrossRef PubMed; \n\nJohnson, D.J.D., Huntington, J.A., Crystal structure of antithrombin in a heparin-bound intermediate state Biochemistry, 42, pp. 8712-8719. , CrossRef PubMed; \n\nLangdown, J., Belzar, K.J., Savory, W.J., Baglin, T.P., Huntington, J.A., The critical role of hinge region expulsion in the induced-fit heparin binding mechanism of antithrombin J. Mol. Biol., 386, pp. 1278-1289. , CrossRef PubMed; \n\nSchedin-Weiss, S., Richard, B., Olson, S.T., Kinetic evidence that allosteric activation of antithrombin by heparin is mediated by two sequential conformational changes Arch. Biochem. Biophys., 504, pp. 169-176. , CrossRef PubMed; \n\nHan, X., Fiehler, R., Broze, G.J., Jr., Isolation of a protein Z-dependent plasma protease inhibitor Proc. Natl. Acad. Sci. U. S. A., 95, pp. 9250-9255. , CrossRef PubMed; \n\nHan, X., Huang, Z.F., Fiehler, R., Broze, G.J., Jr., The protein Z-dependent protease inhibitor is a serpin Biochemistry, 38, pp. 11073-11078. , CrossRef PubMed; \n\nHuang, X., Dementiev, A., Olson, S.T., Gettins, P.G.W., Basis for the specificity and activation of the serpin protein Z-dependent proteinases inhibitor as an inhibitor of membrane-associated factor Xa J. Biol. Chem., 285, pp. 20399-23409. , CrossRef PubMed; \n\nHan, X., Fiehler, R., Broze, G.J., Jr., Characterization of the protein Z-dependent protease inhibitor Blood, 96, pp. 3049-3055. , PubMed; \n\nHuang, X., Swanson, R., Broze, G.J., Jr., Olson, S.T., Kinetic characterization of the protein Z-dependent protease inhibitor (ZPI) reaction with blood coagulation factor Xa J. Biol. Chem., 283, pp. 29770-29783. , CrossRef PubMed; \n\nRezaie, A.R., Manithody, C., Yang, L., Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor. Both active site and exosite interactions are required for inhibition J. Biol. Chem., 280, pp. 32722-32728. , CrossRef PubMed; \n\nRezaie, A.R., Bae, J.-S., Manithody, C., Qureshi, S.H., Yang, L., Protein Z-dependent protease inhibitor binds to the C-terminal domain of protein Z J. Biol. Chem., 283, pp. 19922-19926. , CrossRef PubMed; \n\nWei, Z., Yan, Y., Carrell, R.W., Zhou, A., Crystal structure of protein Z-dependent inhibitor complex shows how protein Z functions as a cofactor in the membrane inhibition of factor X Blood, 114, p. 366203667; \n\nHuang, X., Yan, Y., Tu, Y., Gatti, J., Broze, G., Jr., Zhou, A., Olson, S.T., Structural basis for catalytic activation of protein Z-dependent protease inhibitor Blood, 120, pp. 1726-1733. , CrossRef PubMed; \n\nHuang, X., Zhou, J., Zhou, A., Olson, S.T., Thermodynamic and kinetic characterization of the protein Z-dependent protease inhibitor (ZPI)-protein Z interaction reveals an unexpected role for ZPI Lys-239 J. Biol. Chem., 290, pp. 9906-9918. , CrossRef PubMed; \n\nVan Deerlin, V.M.D., Tollefsen, D.M., The N-terminal acidic domain of heparin cofactor II mediates the inhibition of-thrombin in the presence of glycosaminoglycans J. Biol. Chem., 266, pp. 20223-20231. , PubMed; \n\nBaglin, T.P., Carrell, R.W., Church, F.C., Esmon, C.T., Huntington, J.A., Crystal structure of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism Proc. Natl. Acad. Sci. U. S. A., 99, pp. 11079-11084. , CrossRef PubMed; \n\nGettins, P.G.W., Olson, S.T., Exosite determinants of serpin specificity J. Biol. Chem., 284, pp. 20441-20445. , CrossRef PubMed; \n\nGriffith, M.J., Noyes, C.M., Tyndall, J.A., Church, F.C., Structural evidence for leucine at the reactive site of heparin cofactor II Biochemistry, 24, pp. 6777-6782. , CrossRef PubMed; \n\nHuang, X., Rezaie, A.R., Broze, G., Jr., Olson, S.T., Heparin is a major activator of the anticoagulant serpin protein Z-dependent protease inhibitor J. Biol. Chem., 286, pp. 8740-8751. , CrossRef PubMed; \n\nMast, A.E., Enghild, J.J., Pizzo, S.V., Salvesen, G., Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: Comparison of 1-proteinase inhibitor, 1-antichymotrypsin, antithrombin III, 2-antiplasmin, angiotensinogen, and ovalbumin Biochemistry, 30, pp. 1723-1730. , CrossRef PubMed; \n\nOhlsson, K., Laurell, C.B., The disappearance of enzyme-inhibitor complexes from the circulation of man Clin. Sci. Mol. Med., 51, pp. 87-92. , PubMed; \n\nOrth, K., Madison, E.L., Gething, M.-J., Sambrook, J.F., Herz, J., Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen activator inhibitor type 1 are internalized by means of the low density lipoprotein-related protein/2-macroglobulin receptor Proc. Natl. Acad. Sci. U. S. A., 89, pp. 7422-7426. , CrossRef PubMed; \n\nStrickland, D.K., Ashcom, J.D., Williams, S., Burgess, W.H., Migliorini, M., Argraves, W.S., Sequence identity between the 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor J. Biol. Chem., 265, pp. 17401-17404. , PubMed; \n\nStrickland, D.K., Kounnas, M.Z., Argraves, W.S., LDL receptor-related protein: A multiligand receptor for lipoprotein and proteinase catabolism FASEB J, 9, pp. 890-898. , PubMed; \n\nPoller, W., Willnow, T.E., Hilpert, J., Herz, J., Differential recognition of 1-antitrypsin-elastase and 1-antichymotrypsin-cathepsin G complexes by the low density lipoprotein receptor-related protein J. Biol. Chem., 270, pp. 2841-2845. , CrossRef PubMed; \n\nKounnas, M.Z., Church, F.C., Argraves, W.S., Strickland, D.K., Cellular internalization and degradation of antithrombin III-thrombin, heparin cofactor II-thrombin, and 1-antitrypsin-trypsin complexes is mediated by the low density lipoprotein receptor-related protein J. Biol. Chem., 271, pp. 6523-6529. , CrossRef PubMed; \n\nMakarova, A., Mikhailenko, I., Bugge, T.H., List, K., Lawrence, D.A., Strickland, D.K., The low density lipoprotein receptor-related protein modulates protease activity in the brain by mediating the cellular internalization of both neuroserpin and neuroserpin-tissue-type plasminogen activator complexes J. Biol. Chem., 278, pp. 50250-50258. , CrossRef PubMed; \n\nStorm, D., Herz, J., Trinder, P., Loos, M., C1 Inhibitor-C1s over-bar-s complexes are internalized and degraded by the low density lipoprotein receptor-related protein J. Biol. Chem., 272, pp. 31043-31050. , CrossRef PubMed; \n\nKasza, A., Petersen, H.H., Heegaard, C.W., Oka, K., Christensen, A., Dubin, A., Chan, L., Andreasen, P.A., Specificity of serine proteinase serpin complex binding to very-low-density lipoprotein receptor and 2-macroglobulin receptor low-density-lipoprotein-receptor-related protein Eur. J. Biochem., 248, pp. 270-281. , CrossRef PubMed; \n\nStefansson, S., Lawrence, D.A., Argraves, W.S., Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2 J. Biol. Chem., 271, pp. 8215-8220. , CrossRef PubMed; \n\nStefansson, S., Muhammad, S., Cheng, X.F., Battey, F.D., Strickland, D.K., Lawrence, D.A., Plasminogen activator inhibitor-1 contains a cryptic high affinity binding site for the low density lipoprotein receptor-related protein J. Biol. Chem., 273, pp. 6358-6366. , CrossRef PubMed; \n\nHorn, I.R., Van Den Berg, B.M.M., Moestrup, S.K., Pannekoek, H., Van Zonneveld, A.J., Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator Thromb. Haemost., 80, pp. 822-828. , PubMed; \n\nJensen, J.K., Dolmer, K., Gettins, P.G.W., Specificity of binding of the low density lipoprotein receptor-related protein (LRP) to different conformational states of the clade e serpins PAI-1 and PN-1 J. Biol. Chem., 284, pp. 17989-17997. , CrossRef PubMed; \n\nGettins, P.G.W., Dolmer, K., The high affinity binding site on plasminogen activator inhibitor-1 (PAI-1) for the low density lipoprotein receptor-related protein (LRP1) is composed of four basic residues J. Biol. Chem., 291, pp. 800-812. , CrossRef PubMed; \n\nRodenburg, K.W., Kjoller, L., Petersen, H.H., Andreasen, P.A., Binding of urokinase-type plasminogen activator plasminogen activator inhibitor-1 complex to the endocytosis receptors 2-macroglobulin receptor low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor Biochem. J., 329, pp. 55-63. , CrossRef PubMed; \n\nFass, D., Blacklow, S., Kim, P.S., Berger, J.M., Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module Nature, 388, pp. 691-693. , CrossRef PubMed; \n\nFisher, C., Beglova, N., Blacklow, S.C., Structure of an LDLR-RAP complex reveals a general mode for ligand recognition by lipoprotein receptors Mol. Cell, 22, pp. 277-283. , CrossRef PubMed; \n\nRudenko, G., Henry, L., Henderson, K., Ichtchenko, K., Brown, M.S., Goldstein, J.L., Deisenhofer, J., Structure of the LDL receptor extracellular domain at endosomal pH Science, 298, pp. 2353-2358. , CrossRef PubMed; \n\nYasui, N., Nogi, T., Kiatao, T., Nakano, Y., Hattori, M., Takagi, J., Structure of a receptor-binding fragment of reelin and mutational analysis reveal a recognition mechanism similar to endocytic receptors Proc. Natl. Acad. Sci. U. S. A., 104, pp. 9988-9993. , CrossRef PubMed; \n\nDolmer, K., Campos, A., Gettins, P.G.W., Quantitative dissection of the binding contributions of ligand lysines of the receptor-associated protein (RAP) to the low density lipoprotein receptor-related protein (LRP1) J. Biol. Chem., 288, pp. 24081-24090. , CrossRef PubMed; \n\nGettins, P.G.W., Dolmer, K., A proximal pair of positive charges provides the dominant ligand-binding contribution to complement-like domains from the LRP (low density lipoprotein-related receptor) Biochem. J., 443, pp. 65-73. , CrossRef PubMed; \n\nSkeldal, S., Larsen, J.V., Pedersen, K.E., Egelund, R., Christensen, A., Jensen, J., Andreasen, P.A., Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low density lipoprotein receptor family, determined by site-directed mutagenesis FEBS J, 273, pp. 5143-5159. , CrossRef PubMed; \n\nNykjaer, A., Petersen, C.M., Moller, B.K., Jensen, P.H., Moestrup, S.K., Holtet, T.L., Etzerodt, M., Andreasen, A.M., Purified 2-macroglobulin receptor/LDL receptor related protein binds urokinase plasminogen activator inhibitor-1 complex. Evidence that the 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes J. Biol. Chem., 267, pp. 14543-14546. , PubMed; \n\nNykjær, A., Kjoller, L., Cohen, R.L., Lawrence, D.A., Garni-Wagner, B.A., Todd, R.F., III, Van Zonneveld, A.-J., Andreasen, P.A., Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor J. Biol. Chem., 269, pp. 25668-25676. , PubMed; \n\nHuai, Q., Mazar, A.P., Kuo, A., Parry, G.C., Shaw, D.E., Callahan, J., Li, Y., Chen, L., Structure of human urokinase plasminogen activator in complex with its receptor Science, 311, pp. 656-659. , CrossRef PubMed; \n\nXu, X., Gårdsvoll, H., Yuan, C., Lin, L.-F., Ploug, M., Huang, M., Crystal structure of the urokinase receptor in a ligand-free form J. Mol. Biol., 416, pp. 629-641. , CrossRef PubMed; \n\nZhou, A., Huntington, J.A., Pannu, N.S., Carrell, R.W., Read, R.J., How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration Nat. Struct. Biol., 10, pp. 541-544. , CrossRef PubMed; \n\nKamikubo, Y., Neels, J.G., Degryse, B., Vitronectin inhibits plasminogen activator inhibitor-1-induced signalling and chemotaxis by blocking plasminogen activator inhibitor-1 binding to the low-density lipoprotein receptor-related protein Int. J. Biochem. Cell Biol., 41, pp. 578-585. , CrossRef PubMed; \n\nSchechter, I., Berger, A., On the size of the active site of proteases Biochem. Biophys. Res. Commun., 27, pp. 157-162. , CrossRef PubMed; \n\nElliott, P.R., Pei, X.Y., Dafforn, T.R., Lomas, D.A., Topography of a 2. 0Å structure of alpha-1-antitrypsin reveals targets for rational drug design to prevent conformational disease Protein Sci., 9, pp. 1274-1281. , CrossRef PubMed; \n\nTucker, H.M., Mottonen, J., Goldsmith, E.J., Gerard, R.D., Engineering of plasminogen activator inhibitor-1 to reduce the rate of latency transition Nat. Struct. Biol., 2, pp. 442-445. , CrossRef PubMed; \n\nEngh, R., Löbermann, H., Schneider, M., Wiegand, G., Huber, R., Laurell, C.B., The S variant of human alpha-1-antitrypsin-activity, structure and implication for function and metabolism Protein Eng., 2, pp. 407-415. , CrossRef PubMed; \n\nOlson, S.T., Gettins, P.G.W., Regulation of proteases by protein inhibitors of the serpin superfamily Prog. Mol. Biol. Transl. Sci., 99, pp. 185-240. , CrossRef PubMed; \n\nDementiev, A., Simonovic, M., Volz, K., Gettins, P.G.W., Canonical inhibitor-like interactions explain reactivity of 1-proteinase inhibitor Pittsburgh and antithrombin with proteinases J. Biol. Chem., 278, pp. 37881-37887. , CrossRef PubMed; \n\nHuang, W., Dolmer, K., Gettins, P.G.W., NMR solution structure of complement-like repeat CR8 from the low density lipoprotein receptor-related protein (LRP) J. Biol. Chem., 274, pp. 14130-14136. , CrossRef PubMed; \n\nDolmer, K., Huang, W., Gettins, P.G.W., NMR solution structure of complement-like repeat CR3 from the low density lipoprotein receptor-related protein (LRP). Evidence for specific binding to the receptor binding domain of human 2-macroglobulin J. Biol. Chem., 275, pp. 3264-3271. , CrossRef PubMed; \n\nSimonovic, M., Dolmer, K., Huang, W., Strickland, D.K., Volz, K., Gettins, P.G.W., Calcium coordination and pH dependence of the calcium affinity of ligand-binding repeat CR7 from the LRP. Comparison with related domains from the LRP and the LDL receptor Biochemistry, 40, pp. 15127-15134. , CrossRef PubMed", "hasCitationDuplums" : false, "userChangeableUntil" : "2017-08-03T11:15:55.000+0000", "publishDate" : "2017-05-05T11:15:55.000+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 4, "ownerInstituteCount" : 20, "directInstituteCount" : 0, "authorCount" : 2, "contributorCount" : 0, "hasQualityFactor" : false, "link" : "/api/publication/26558214", "label" : "Gettins PGW et al. Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance. (2016) BIOCHEMICAL JOURNAL 0264-6021 1470-8728 473 15 2273-2293", "template" : "